Insured Price of Glivec Set at 25,000 Won on Condition of 30% of Complementary Donation

Published: 2001-09-19 06:57:00

Updated: 2001-09-19 06:57:00

The insured price of Glivec, which has attracted attention as a treatment for marrow-type chronic leukemia, has increased to 25,000 won on the condition that 30% of the quantity of the drug would be donated to patients suffering from the disease. However, since the price was revised under the pri...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK